Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000223265 | SCV000273841 | likely benign | Hereditary cancer-predisposing syndrome | 2015-02-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000459167 | SCV000558320 | likely benign | Ataxia-telangiectasia syndrome | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000223265 | SCV000682188 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001640341 | SCV001856216 | benign | not provided | 2015-05-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818519 | SCV002065053 | likely benign | not specified | 2017-08-29 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000223265 | SCV002534590 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-30 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV001818519 | SCV004243441 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589930 | SCV005082829 | benign | Familial cancer of breast | 2024-05-16 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |